[Application of multi-stage competing risk model to survival data].

Li, W Q; Yang, L; Wang, S F; Zhang, L W; Sheng, C; Huang, Y B

Li, W Q; Yang, L; Wang, S F; Zhang, L W; Sheng, C; Huang, Y B.

Afiliação

Li WQ; Project Office, Tianjin Women's and Children's Health Center, Tianjin 300070, China.
Yang L; Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Wang SF; Department of Epidemiology & Bio-statistics, School of Public Health, Peking University Health Science Center, Beijing 100191, China.
Zhang LW; Department of Cancer Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Sheng C; Department of Cancer Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Huang YB; Department of Cancer Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.

Zhonghua Yu Fang Yi Xue Za Zhi ; 55(12): 1524-1529, 2021 Dec 06.

Article em Zh | MEDLINE | ID: mdl-34963255

Assuntos

Neoplasias da Próstata; Humanos; Masculino; Modelos de Riscos Proporcionais; Risco; Medição de Risco; Fatores de Risco; Análise de Sobrevida

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google